Table 3 Clinicopathological characteristics of the samples with concurrent mutations in the four genomic subtypes.
No. | Gender | Age | Breslow (mm) | Anatomic site | Sun related site | Histological subtype | Gene | Amino acid change | Allele frequency (%) |
---|---|---|---|---|---|---|---|---|---|
2 | M | 79 | 2.7 | Trunk | Occasional exposed | SSM | BRAF | p.Gly464Arg | 6.8 |
NF1 | p.Arg711Cys | 4.7 | |||||||
28 | F | 58 | 0.7 | Lower extremities | Occasional exposed | SSM | NRAS | p.Glu62Gln | 8.0 |
NRAS | p.Gln61Arg | 8.0 | |||||||
58 | M | 69 | 0.4 | Trunk | Occasional exposed | SSM | BRAF | p.Leu597Arg | 4.1 |
NRAS | p.Gly12Ser | 5.0 | |||||||
62 | M | 66 | 4.2 | Head and neck | Usually exposed | LMM | KRAS | p.Gly12Val | 80.8 |
NF1 | p.Trp1512* | 30.8 | |||||||
68 | M | 54 | 0.7 | Head and neck | Usually exposed | SSM | BRAF | p.Val600Glu | 25.4 |
NF1 | p.Lys1844Th | 6.3 | |||||||
71 | F | 85 | 3 | Acral | Non exposed | ALM | KIT | p.Tyr553Ser | 31.8 |
KIT | p.Tyr578Cys | 43.9 | |||||||
80 | F | 73 | 0.3 | Upper extremities | Occasional exposed | SSM | BRAF | p.Val600Glu | 2.0 |
NRAS | p.Gln61Arg | 3.0 | |||||||
84 | F | 57 | 2 | Upper extremities | Occasional exposed | SSM | BRAF | p.Leu584Phe | 23.1 |
NRAS | p.Gln61Leu | 24.0 | |||||||
107 | M | 59 | 6 | Head and neck | Usually exposed | NM | KRAS | p.Gln61Arg | 5.3 |
KRAS | p.Ala146Val | 10.6 | |||||||
NF1 | p.Gln1070* | 13.5 |